Lithium in Psychiatric Therapy: Celebrating 75th Anniversary

Dear Colleagues,

This Special Issue celebrates the 75th anniversary of introducing lithium into modern psychiatry, hallmarked by a seminal publication of John Cade in the Medical Journal of Australia in 1949.

In such vein, we call for papers (especially review papers) demonstrating how, after three-quarters of a century, lithium has been consolidated as one of the most important drugs in psychiatry nowadays. Therefore, historical accounts showing developments in the lithium treatment of mania, depression (including the augmentation of antidepressant drugs), and lithium prophylaxis for mood disorders are welcome.

The chronicle tales of the anti-suicidal, immunomodulatory, antiviral, and neuroprotective (antidementia) effects of lithium are invited.  The papers in this Special Issue may cover a number of areas, such as the expansion of genetic studies on lithium, fluctuating views on the adverse effects of this ion (e.g., on kidney and thyroid function), or the use of lithium in pregnancy. Any other developmental stories about lithium over the past 75 years (e.g., a history of IGSLI) are welcome.

Prof. Dr. Janusz K. Rybakowski
Dr. Ewa Ferensztajn-Rochowiak
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• lithium
• bipolar disorder
• mania
• depression
• the prevention of recurrences
• suicide
• dementia
• immunomodulation
• genetics
• kidney function